Story perspectives

New Opioid DFNZ Promises Safer Pain Management, Experts Cautious

4/3/2026

Summary

Story summary

National Institutes of Health (NIH) researchers developed N-desethyl-fluornitrazene (DFNZ), a new opioid that shows potential for safer pain management.
In rodent studies, DFNZ produced strong analgesia while avoiding tolerance and withdrawal symptoms.
The compound acts differently in the brain by slowing dopamine release, which may reduce abuse risk.
Experts caution that thorough evaluation is needed to prevent past opioid misuse as the team moves toward human trials.

1 of 1

Story summary

National Institutes of Health (NIH) researchers developed N-desethyl-fluornitrazene (DFNZ), a new opioid that shows potential for safer pain management.
In rodent studies, DFNZ produced strong analgesia while avoiding tolerance and withdrawal symptoms.
The compound acts differently in the brain by slowing dopamine release, which may reduce abuse risk.
Experts caution that thorough evaluation is needed to prevent past opioid misuse as the team moves toward human trials.